Received Dec 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
patient got only the MenB portion of PENMENVY.; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate dose of vaccine administered in a patient who received Men ABCWY NVS (Penmenvy) for prophylaxis. On 16-DEC-2025, the patient received Penmenvy. On 16-DEC-2025, an unknown time after receiving Penmenvy, the patient experienced inappropriate dose of vaccine administered (Verbatim: patient got only the MenB portion of PENMENVY.). The outcome of the inappropriate dose of vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-DEC-2025 The reporter wanted to know what the steps were after this incident. The batch number was not provided upon follow up with the reporter.